A Biomedical (Biochemical) Engineering Ph.D. with over 5 years’ research experience in mammalian cell culture, antibody production process development, protein purification, valuation of high-quality monoclonal antibodies and recombinant proteins, and the development of novel specific targeting cancer therapies.
Principal Scientist at Bristol Myers Squibb
Doctor of Philosophy - PhD, Biomedical Engineering